Management of recurrent desmoid tumor after surgery and radiation: role of cytotoxic and non-cytotoxic therapies.
Desmoid tumors frequently reoccur after surgery and radiation. The therapy of recurrent desmoid tumors is often unsatisfactory. Additional surgery may not be feasible. Drug therapy can sometimes be helpful, and even remarkably successful. Unfortunately, the rarity of desmoids precludes conduct of large clinical trials. Most series are small, anecdotal, and lack internal consistency. The lack of real understanding of desmoid biology has meant that therapies have, until now, been empirical rather than rationally designed. Nevertheless, a range of drugs is available to be utilized, including hormonal or hormonal antagonist therapy, cyclooxygenase inhibitors, biologic agents and cytotoxic chemotherapy. This review will utilize a patient case report to illustrate the problems frequently encountered in choosing therapy for patients with recurrent desmoid tumors. Based on this case, the review will explore the options available, as well as the process through which treatment options may be evaluated.
Samuels
B L
BL
Section of Hematology/Oncology, University of Illinois at Chicago, Park Ridge 60068, USA. brian.samuels@advocatemedical.com
D000328:Adult; D003131:Combined Modality Therapy; D005260:Female; D018222:Desmoid Tumors / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D005542:Forearm; D006801:Humans